Discontinuation and reinitiation of dual-labeled glp-1 receptor agonists among us adults with overweight or obesity
The late-breaking results will highlight who may benefit from these therapies, adults living with overweight or obesity, including those with type 2 diabetes (T2D), what the data show on efficacy, safety, and tolerability, when and where the findings will be presented during the ADA meeting, and why they are important for advancing long-term weight management and treatment adherence
Clinical studies using Curcushine microcapsules have demonstrated significant improvements in skin luminosity, homogeneity, wrinkle depth, and dark spot coverage when curcumin is delivered in water-dispersible, microencapsulated formats. 3 smart sales strategies for natural retailers Think fun formats : Carry a variety of formats, as consumers especially like to ingest nutricosmetics in non-pill form, says Harris
That is more than triple the 3% of adults who reported doing so just two years prior in 2024
